Pancreatic Cancer Research

ResearcherNational Cheng Kung UniversityActive in the last 2 years

Yi‐Ching Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7694-2067; OpenAlex author ID A5056228804. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Stromal CCL2/CXCL10/SPARC axes drive pro-tumor CHI3L1 expression for microenvironmental modulation in pancreatic cancer progression and therapeutic innovation. Last author DOI 10.1186/s12929-026-01295-2↗
  2. Macrophage activation determines muscle wasting in pancreatic cancer. Co-author DOI 10.1038/s41388-025-03434-9↗
  3. Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancer. Co-author DOI 10.1186/s13148-020-00878-6↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ya‐Chin Hou · 3 shared papers, 2020–2026 · strength 0.64
  2. Pei-Chia Su · 2 shared papers, 2025–2026 · strength 0.56
  3. Yan-Shen Shan · 1 shared paper, 2026 · strength 0.36
  4. Po-Hsien Huang · 2 shared papers, 2020–2025 · strength 0.29
  5. Li-Yun Ding · 2 shared papers, 2020–2025 · strength 0.29
  6. Yan‐Shen Shan · 2 shared papers, 2020–2025 · strength 0.29
  7. Szu-Ying Chen · 1 shared paper, 2025 · strength 0.20
  8. Chih‐Han Chang · 1 shared paper, 2025 · strength 0.20
  9. Hao‐Chen Wang · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.